Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Major Food Ingredients Firm Chr. Hansen Installs Fill-It™

Published: Friday, October 25, 2013
Last Updated: Friday, October 25, 2013
Bookmark and Share
To meet increasing demand for its high quality bacterial starter cultures.

TAP Biosystems has announced that its Fill-It™; automated benchtop vial filling system has been installed at Chr. Hansen, a global bioscience company that develops natural ingredients for the food and nutritional industries.

The system, which is being utilized for the first time in the food industry, will be used to improve processing throughput of large batches of vials containing bacterial starter cultures for use in variety of fermented food products.

Scientists at Chr. Hansen have factory tested and installed the Fill-It to decrease production time of their culture inoculation material. It will also be used to convert non-Kosher strains to ones that are Kosher certified.

Each vial contains 4mL of a yeast extract media or a thick milk based culture containing up to 100,000 cells/mL of bacterial strains, including Lactobacillus, Lactococcus and Bifidobacterium.

These starter cultures will be distributed globally to Chr. Hansen’s production sites to be used as the first step in producing cultures for yoghurts, fermented milks and cheese, or for wine fermentation.

Microbiologists at Chr. Hansen selected Fill-It for this application because it has the capability to double batch production and more importantly, maintain high quality, contamination-free cultures.

James Lemanczyk, Microbial Service Technician at Chr. Hansen explained: “We were using a huge semi-automated filling system which took two people to operate with one technician loading vials at one end and another one to remove and package the vials at the other. It was very time consuming and we knew we had to upgrade our process to make it not only more efficient but also more consistent. We assessed two automated filling systems but chose Fill-It because the system is so compact we can use it in a standard laminar flow cabinet, we can also fit the system with a disposable tube set, as well as adapt it to fit 5mL sterile Nunc tubes. These features will not only save time with batch set-up but will help us ensure there is minimal operator interaction to produce cultures that are kept pure and contamination free during each run.”

Lemanczyk added: “We also liked the fact that TAP’s staff were willing to work with us in partnership to re-calibrate the Fill-It system to precisely dispense milk cultures. These are challenging as they can be gaseous and are very thick due to the cells lactic acid production which thickens the milk and their bacterial slime production. Now we can fill accurately, we’re really looking forward to implementing the Fill-It system into our new dispensing process.”

Stephen Guy, Fill-It Product Manager at TAP Biosystems commented: “Use of the Fill-It system for its time saving and quality benefits is well established in many international cell banks and we’re delighted that our first installation in the food industry is at such a prestigious nutritional ingredients company. Chr. Hansen’s adoption of our state-of-the-art automation indicates to food ingredients firms looking to improve batch productivity and product consistency that adding a Fill-It system in their workflow is a forward thinking investment.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck and TAP Biosystems Finalists for “Best Collaboration Award”
Recognizing ambr250 as a breakthrough technology for process development.
Wednesday, October 08, 2014
TAP and Gallus Co-host Free Webinar
Explaining the benefits of using ambr15 microbioreactors for DoE.
Wednesday, October 01, 2014
New Webinars Explore Feed Strategy Challenges Using Mini Bioreactors
Detailing how to achieve consistent feeding regimes for reproducible scale-up.
Thursday, September 25, 2014
New Webinar on Mimicking Perfusion Culture Using Micro Bioreactors
Presents validation data for improving media screening and process optimization.
Friday, February 14, 2014
Scientific News
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!